Facebook
Twitter
LinkedIn
ForwardWisconsin Review of the San Antonio Breast Cancer Symposium WAHO-SABCS - January 29, 2022
Claiming Credit
Thank you for participating in this program. Once logged in, please click on "Register" or "Take Course" button above or on the right-hand side and your enrollment will be recorded. You will be prompted to complete the evaluation and claim your credit on the following page.
To optimally care for their patients with breast cancer, oncologists need information on the latest research findings and best practices for managing the disease. In particular, they need to know about recent advances in localized and systemic therapy, especially immunotherapy and targeted therapy, and they need updates regarding treatment for specific subtypes of breast cancer, including HER2-positive, triple-negative, and hormone receptor-positive breast cancer. They also need to learn about emerging options for using precision medicine in the care of patients with breast cancer
Target Audience
Pharmacists, Physician Assistants, Nurses, Nurse Practitioners
Learning Objectives
At the end of this educational activity, participants should be able to:
- Discuss recent advancements in the management of HER2-positive, triple-negative, and hormone receptor-positive breast cancer.
- Evaluate immunotherapy options for treating patients with breast cancer.
- Apply new knowledge about localized and systemic therapies to the care of patients with breast cancer.
Saturday January 29, 2022
7:40 AM Virtual Registration Open
7:50 AM Welcome and Introductions
Benjamin M. Parsons, DO
President, Wisconsin Association of Hematology and Oncology
Session I Moderator: Sailaja Kamaraju, MD, MS
Medical College of Wisconsin
8:00 AM Localized Therapy: Updates from a Surgery Perspective
Meeghan A Lautner, MD, FACS
University of Wisconsin School of Medicine and Public Health
8:30 AM Localized Therapy: Recent Advances in Radiotherapy for Breast Cancer
Adam Currey, MD
Medical College of Wisconsin
9:00 AM Break
9:10 AM Advances in HER2 Positive Breast Cancer
William Gradishar, MD Robert H. Lurie Comprehensive Cancer Center of Northwestern University Northwestern University Feinberg School of Medicine
9:40 AM Break
9:50 AM Updates in Triple Negative Breast Cancer
Lubna Chaudhary, MD, MS
Medical College of Wisconsin
10:20 AM Break
Session II Moderator: Kari B. Wisinski, MD
University of Wisconsin Carbone Cancer Center
10:30 AM Updates in Hormone Receptor Positive Breast Cancer
Ruth O’ Regan, MD
University of Rochester
11:00 AM Break
11:10 AM Precision Medicine and Genomic Update
Mark E. Burkard, MD, PhD
University of Wisconsin Carbone Cancer Center
11:40 AM Break
11:50 AM CNS Metastasis in Breast Cancer and Treatment Updates
Sailaja Kamaraju, MD, MS Medical College of Wisconsin
12:20 PM Wrap-Up and Acknowledgements
Built in 1893, The Pfister Hotel in Milwaukee has been a hotel icon for well over a century. As one of the best hotels in Milwaukee and the Midwest, it’s located near the historic Third Ward and continues to celebrate a grand tradition of gracious service and impeccable style. From the moment guests arrive they’ll notice the extraordinary architecture inside and out punctuated by a welcoming ambiance from staff and fellow guests alike.
Physicians: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint provider ship of Boston University School of Medicine and the Wisconsin Association of Hematology and Oncology.
Boston University School of Medicine designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Nurses: Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity has been provided by Boston University School of Medicine Continuing Nursing Education and jointly provided by the Wisconsin Association of Hematology and Oncology.
Contact Hours: 3.0, of which 2.50 are pharmacology credit worthy
Available Credit
- 3.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 3.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 3.00 ANCC
- 2.00 ANCC Pharmacology
- 3.00 Participation